📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

Cohance Lifesciences Ltd

Common Name
Cohance Lifesciences
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,212
Ticker
COHANCE
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Cohance Lifesciences Limited, established in 1989 and headquartered in Hyderabad, India, is a prominent contract development and manufacturing organization (CDMO) specializing in the pharmaceutical an...

Cohance Lifesciences's Financial Statements Preview

Below are the financial statements of Cohance Lifesciences, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of INR
2024
2023
Income——
Revenue from operations
10,513.54a
13,403.29a
Other income
619.05a
463.64a
Total income
11,132.59a
13,866.93a
Expenses——
Cost of materials consumed
-2,658.79a
-4,300.79a
Changes in inventories of work-in-progress and finished goods
-491.56a
-209.44a
Manufacturing expenses
-1,334.76a
-1,770.6a
Employee benefits expense
-1,359.2a
-1,182.49a
Finance cost
-74.51a
-128.11a
Depreciation and amortization expense
-545.96a
-479.86a
Other expenses
-611.1a
-617.22a
Total expenses
-7,075.87a
-8,269.63a
Profit before tax
4,056.72a
5,597.3a
Tax expense——
Current tax
-995.75a
-1,462.74a
Deferred tax
-65.92a
-43.38a
Prior year tax
-7.76a
-21.72a
Profit/(loss) for the year
3,002.81a
4,112.9a
Download Data

Verified Sources Behind Cohance Lifesciences’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Cohance Lifesciences’s data sources below and access millions more through our Disclosure Search.

a. Cohance Lifesciences's Annual Report 2024
a. Cohance Lifesciences's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?